General fitness, health and nutrition · Public discussion

Hydroxyurea suppresses erythrocytosis

Started by Email address hidden · · Last activity · 1 post · 205 views

Thread details

What we know about this thread

Original section
General fitness, health and nutrition
Published
25 March 2007
Last activity
25 March 2007
Original author
Email address hidden
Posts
1
Discussion status
Public discussion
Total views
205
Views / 30 days
0

The navigation and discussion metadata provide context. Posts remain in their original chronological order.

Showing posts 1–1 of 1
Posts remain in their original chronological order.

Text size
  1. Cardiol Rev. 2007 Jan-Feb;15(1):31-4. Links
    Blood is thicker than water: the management of hyperviscosity in
    adults with cyanotic heart disease.DeFilippis AP, Law K, Curtin S,
    Eckman JR.
    Department of Medicine, Division of General Medicine, Emory University
    School of Medicine, Atlanta, Georgia 30303, USA. [email hidden]

    Complications of chronic hypoxia, including erythrocytosis,
    hyperviscosity, abnormalities of hemostasis, cerebral abscesses,
    stroke, and endocarditis, are among the most common consequences of
    cyanotic heart disease in adults. The compensatory erythrocytosis of
    cyanotic heart disease can become pathologic by causing an increase in
    blood viscosity, thereby decreasing perfusion and resulting in
    decreased total oxygen delivery and increased risk of venoocclusive/
    hyperviscosity syndrome. Treatment of hyperviscosity secondary to
    erythrocytosis in cyanotic heart disease is controversial. Data is
    limited but suggest that phlebotomy has the potential to increase
    exercise capacity, reduce the symptoms of hyperviscosity, and reduce
    the potential risk of vasoocclusive disease in selected patients with
    polycythemia secondary to cyanotic heart disease. Unfortunately,
    repeated phlebotomy can quickly lead to iron deficiency, resulting in
    microcytic erythrocytes that induce higher viscosity than normocytic
    erythrocytes, which may increase the risk for venoocclusive events.
    There are limited data on the use of hydroxyurea to suppress
    erythrocytosis in this patient population. The authors conclude that
    until newer approaches to decreasing hematocrit without inducing iron
    deficiency are shown to be safe and efficacious, phlebotomy should
    only be used for the acute resolution of hyperviscosity symptoms. In
    addition, the use of hydroxyurea should be limited to patients with
    recurrent symptoms.

    PMID: 17172881 [PubMed - indexed for MEDLINE]

    Who loves ya.
    Tom

    Jesus Was A Vegetarian!
    http://jesuswasavegetarian.7h.com

    Man Is A Herbivore!
    http://tinyurl.com/a3cc3

    DEAD PEOPLE WALKING
    http://tinyurl.com/zk9fk

Active in the last 60 minutes

Active in this thread

0 users · 0 guests ·0 bots ·0 total

No signed-in users are active right now.

No known search crawlers active right now.